about
Diaphragm perforation after radiofrequency ablation for liver malignancyRecanalization of an occluded intrahepatic portosystemic covered stent via the percutaneous transhepatic approachComparison and validation of International Consensus Diagnostic Criteria for diagnosis of autoimmune pancreatitis from pancreatic cancer in a Taiwanese cohortPrototype of biliary drug-eluting stent with photodynamic and chemotherapy using electrospinning.Preoperative diagnosis of gastric tumors by three-dimensional multidetector row ct and double contrast barium meal study: correlation with surgical and histologic results.The pilot experience upon surgical ablation of large liver tumor by microwave system with tissue permittivity feedback control mechanism.Association of novel chymotrypsin C gene variations and haplotypes in patients with chronic pancreatitis in Chinese in Taiwan.Doxorubicin-modified magnetic nanoparticles as a drug delivery system for magnetic resonance imaging-monitoring magnet-enhancing tumor chemotherapy.Overweight increases the risk of malignancy in patients with pancreatic mucinous cystic neoplasms.Quantification of hepatic steatosis: a comparison of the accuracy among multiple magnetic resonance techniques.Metallic ureteral stents in malignant ureteral obstruction: clinical factors predicting stent failure.Perfusion parameters of dynamic contrast-enhanced magnetic resonance imaging predict outcomes of hepatocellular carcinoma receiving radiotherapy with or without thalidomide.Current role of selective internal radiation with yttrium-90 in liver tumors.Dynamic Contrast-enhanced MR Imaging of Advanced Hepatocellular Carcinoma: Comparison with the Liver Parenchyma and Correlation with the Survival of Patients Receiving Systemic Therapy.Disease-free survival assessment by artificial neural networks for hepatocellular carcinoma patients after radiofrequency ablation.Polymersomes conjugated with des-octanoyl ghrelin and folate as a BBB-penetrating cancer cell-targeting delivery system.One-stage hybrid repair to thoracoabdominal aortic aneurysm.Comparison of characteristics and transarterial chemoembolization outcomes in patients with unresectable hepatocellular carcinoma and different viral etiologies.Association of tumour necrosis factor alpha promoter haplotype with chronic pancreatitis.Simulation of portal hemodynamic changes in a donor after right hepatectomy.Hepatic necro-inflammation and elevated liver enzymes: evaluation with MRI perfusion imaging with gadoxetic acid in chronic hepatitis patients.A pilot study of hepatic arterial infusion of chemotherapy for patients with advanced hepatocellular carcinoma who have failed anti-angiogenic therapy.A novel photodynamic therapy-based drug delivery system layered on a stent for treating cholangiocarcinoma.Pneumatosis intestinalis and hepatic portal venous gas after CPR.Splenic vein thrombosis and Klebsiella pneumoniae septicemia after endoscopic gastric variceal obturation therapy with N-butyl-2-cyanoacrylate.Association of cystic fibrosis transmembrane conductance regulator (CFTR) mutation/variant/haplotype and tumor necrosis factor (TNF) promoter polymorphism in hyperlipidemic pancreatitis.Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study.Initial institutional experience of uncooled single-antenna microwave ablation for large hepatocellular carcinoma.Three-dimensional analysis for radio-frequency ablation of liver tumor with blood perfusion effect.Hepatic epithelioid hemangioendothelioma in Taiwan: a clinicopathologic study of six cases in a single institution over a 15-year period.Autoimmune pancreatitis associated with high prevalence of gastric ulcer independent of Helicobacter pylori infection status.Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma.Diffuse cirrhosis-like recurrence of hepatocellular carcinoma after curative resection.Increase diagnostic accuracy in differentiating focal type autoimmune pancreatitis from pancreatic cancer with combined serum IgG4 and CA19-9 levels.The significance of endograft geometry on the incidence of intraprosthetic thrombus deposits after abdominal endovascular grafting.Assessing hepatic fibrosis: comparing the intravoxel incoherent motion in MRI with acoustic radiation force impulse imaging in US.Cystic fibrosis transmembrane conductance regulator gene variants are associated with autoimmune pancreatitis and slow response to steroid treatment.Human cationic trypsinogen but not serine peptidase inhibitor, Kazal type 1 variants increase the risk of type 1 autoimmune pancreatitis.Recombinant factor VIIa use in refractory ulcer bleeding in uremic patientDynamic MRI signals in the second week of radiotherapy relate to treatment outcomes of hepatocellular carcinoma: a preliminary result
P50
Q30630950-93D26B60-1BF7-4BD7-8D74-DCF99A946FBAQ33945900-6706E949-F0CC-49A1-A1DD-AEF326A61E22Q34071814-C7186920-F18C-49F1-8842-89635AB8E8DBQ34136213-86F3B707-98DB-4509-A586-944B382751B9Q34585840-9B8E79EA-82A9-4C81-8F7B-103DACA84B72Q34761934-16679872-2731-4354-B3A1-4D5589D0A693Q34978689-18CAA987-1306-41E0-A7B3-E3D32EB8CB3CQ36044414-6F9E24BE-70DA-4481-A551-3451B205DC3AQ36152949-D1165C2D-E21E-40A8-A842-D63838A084F9Q38162260-DC4D88E0-6DC6-4E76-B797-5362CF2C2BDAQ38176410-9800AFA6-3AFB-48A1-BCE0-688ECDFADB5CQ38414698-6B6908F2-CA23-47D1-9CE4-F41966ECC699Q38786064-9D6AB3A2-14F4-46B6-8271-17BBEC935E66Q38832704-2AC320A6-9AC1-4D3F-84E2-CDAB8CE5F077Q39002499-7D719096-7EB9-4F13-91D2-68C4777A38E0Q39025311-AC79EB97-471D-4904-93FB-8CD89A81A504Q39200555-AEA74620-176F-4CC4-8387-3341F9B0AA16Q42240805-AD5873DC-11AE-4A8B-AF33-339996EE53C4Q42836074-21259BCD-55D0-4ABD-9D47-2BEDB48E9C43Q43101397-5CFF533E-1AB3-4360-BC33-EFC9880D9D6CQ43979722-CCAE5DBE-B892-4B6C-9C1D-2EB1033430C9Q44681461-6096402D-16F5-4A42-A521-71E6D8890756Q46256379-C2E72F86-479E-48FD-9E73-388A9D33124AQ46376083-66CB712F-55FC-496A-AD3A-183DB6843ECCQ46904976-A7DA91F7-AD27-40C9-A226-6B67EA137AB9Q46915234-09F19EB5-2BD8-4D41-8915-E8FFB6C9C5D0Q49498614-8AB49E05-1123-4C67-9220-741F6B64FDACQ51050469-FCE05DA0-9BEF-487B-A370-03AC346DB25DQ51317268-EBC30E14-074A-40B2-BB24-52174B84F221Q51568390-95C134AA-EDDA-4DEA-B8A2-D1E39DB8716AQ51774250-DF8AF4DC-BD84-443A-B9E1-16295CA6F2E3Q52943992-E0E765E8-595B-4DA4-9C82-2EDCA1AFE21CQ52985697-7567CA7C-40DF-483B-A515-41531AB3C646Q53083303-AC700EF4-8762-403C-81DD-9B94A3030D46Q53328888-E213D0CA-6676-4451-B5A4-88D00ED571FBQ53500470-56DA4AA8-6660-4679-953D-3AD9320A5C1BQ53544389-C5E46C95-7388-415B-8CE6-CABA3804D817Q55058320-0B38219C-A6F8-4EF1-B426-E0871211DE21Q58756608-94D56576-793F-421C-A7EC-3B9730C4059AQ80085821-248EC707-7FB3-4FC6-AD19-B439B328B513
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Po-Chin Liang
@ast
Po-Chin Liang
@en
Po-Chin Liang
@es
Po-Chin Liang
@nl
type
label
Po-Chin Liang
@ast
Po-Chin Liang
@en
Po-Chin Liang
@es
Po-Chin Liang
@nl
prefLabel
Po-Chin Liang
@ast
Po-Chin Liang
@en
Po-Chin Liang
@es
Po-Chin Liang
@nl
P106
P1153
7203036028
P31
P496
0000-0002-6674-2926